Evolus, Inc. is a performance beauty company focusing on the cash-pay aesthetic market. Analysts project breakeven in 2026 with a 66% annual growth rate. However, the company's high debt-to-equity ratio poses a risk for investors.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing